地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172431432
传真：17754422825
邮箱：sales@amyjet.com
艾美捷科技代理Badrilla 品牌。
Badrilla公司拥有一支由经验丰富的科学家和工程师组成的研发团队，他们在心血管研究领域具有深厚的专业知识和丰富的实践经验，特别是蛋白质S-棕榈酰化在疾病中的作用，并确保在您的实验系统中准确、精确和可靠地测量生物标志物浓度。Badrilla公司的主要产品包括用于心血管研究的各种高质量试剂和工具。这些产品旨在帮助研究人员深入了解心血管系统的生理和病理过程，从而推动心血管疾病的治疗和预防。
具体来说，Badrilla公司的产品和服务可能涵盖以下几个方面：
（1）蛋白质研究工具：提供高质量的蛋白质试剂，帮助研究人员研究蛋白质的结构和功能，以及蛋白质在心血管疾病中的作用。
（2）心血管研究试剂：包括用于研究心肌兴奋-收缩耦联、心律失常、心肌肥大和心脏衰竭等心血管疾病的试剂。
（3）定制服务：根据研究人员的具体需求，提供定制化的试剂和服务，以满足其独特的研究需求。
<<< " data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Badrilla品牌"> 艾美捷科技代理Badrilla品牌
艾美捷科技特约代理Biogems产品。
BioGems意为生物钻石，其产品涵盖多种荧光标记的流式抗体、具有生物活性的功能性抗体，以及流式细胞术辅助试剂，如溶血剂和破膜剂等。BioGems产品全部在美国生产，目前已拥有超过500种流式试剂和600余种重组蛋白产品。
Through the establishment of joint collaborations with reputable manufacturers of top-quality life-science research products such as PeproTech Inc., BioGems has positioned itself to become a highly competitive source for a wide-range of recombinant protein and flow-cytometry reagents. Currently, our catalog contains more than 600 recombinant proteins and over 500 flow cytometry reagents. To keep up with the rapidly advancing research fronts, BioGems continuously adds new products to its catalog. All of our products are subjected to a thorough and rigorous quality and performance testing to ensure that each and every product meets the highest established standards. Providing our customers with the highest-quality products at affordable prices is our goal. We are confident that the unique business arrangements of BioGems together with our highly skilled and experienced personnel will enable us to achieve this goal.
主要产品分类：
（1）Flow Cytometry
Conjugated Antibodies
SAFIRE Functional Antibodies
Isotype Controls
Custom and Bulk Reagents
Purified Antibodies
Buffers and Solutions
（2）Recombinant Proteins
Growth Factors & Cytokines
Animal-Free Cytokines
Chemokines
Neurotrophins
Other Proteins
Anti Cytokine & Chemokine Antibodies
（3）Small Molecules
Receptor Antagonist and Inhibitors
Receptor Agonists and Activators
（4）Pre-Coated Elisa Kits
Human
Mouse
Rat
" data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="BioGems"> BioGems
艾美捷科技代理ATTO Biotech全系列产品。
ATTO Biotech专注于开发和提供生命科学研发用的创新产品及服务。公司位于中国上海，主要为全球生物医药类企业及研发机构提供高度专业化的细胞培养材料和技术服务。爱拓生物科技推出的含组织特异性基质成分细胞培养添加剂，突破了传统细胞培养技术的瓶颈，为全球医药和医学生物学研究者提供了简单、精确和高效的解决方案，是划时代技术革命性产品。
ATTO BIOTECH is a German company based inShanghaiChina. We are no giant on an international scale but a global leader in producing cell culture supplements containing tissue-specific decellularized extracellular matrix (ECM) components. Customers choose ATTO BIOTECH for its true research tools of tomorrow to create clinically relevant in vitro solutions that fundamentally change the way we understand human diseases. Our range of highly innovative products has wide applications in life sciences industries and academic institutions.
主要产品包括：
心脏组织特异性细胞外基质添加剂
(Cat# ECM201) heart-specific ECM supplements (hECMs), 10×
动/静脉血管组织特异性细胞外基质添加剂
(Cat# ECM202) artery/vein-specific ECM supplements (aECMs/vECMs), 10×
脑组织特异性细胞外基质添加剂
(Cat# ECM203) brain-specific ECM supplements (bECMs), 10×
胃肠组织特异性细胞外基质添加剂
(Cat# ECM204) gastrointestine-specific ECM supplements (gECMs), 10×
食管组织特异性细胞外基质添加剂
(Cat# ECM205) esophagus-specific ECM supplements (eECMs), 10×
肾胀组织特异性细胞外基质添加剂
(Cat# ECM206) kidney-specific ECM supplements (kECMs), 10×
肝组织特异性细胞外基质添加剂
(Cat# ECM207) liver-specific ECM supplements (liECMs), 10×
脾组织特异性细胞外基质添加剂
(Cat# ECM208) spleen-specific ECM supplements (sECMs), 10×
肺组织特异性细胞外基质添加剂
(Cat# ECM209) lung-specific ECM supplements (luECMs), 10×
气管组织特异性细胞外基质添加剂
(Cat# ECM210) trachea-specific ECM supplements (tECMs), 10×
" data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="ATTO Biotech"> ATTO Biotech
艾美捷科技代理SeraCare对照及参比物质。
艾美捷科技有限公司，自2018年与SeraCare（现隶属于LGC Clinical Diagnostics）合作以来，长期为中国客户提供包括SeraSeq系列参比物质，领域包括肿瘤、生殖健康和遗传病。SeraCare研发和生产一系列临床参比物质，可以用于任何研发阶段，以确保临床基因组学检测结果的准确性。
SeraCare参比物质涵盖的范围：
1）Next Generation Sequencing
2）Sanger Sequencing
3）Real-time PCR and digital PCR (dPCR)
4）Microarray
主要特点
1）Ready-to-use reference materials covering clinically-relevant variants and all variant types - SNVs, INDELS, CNVs, and RNA fusions
2）Highly multiplexed - provide significantly more data per NGS run, saving sequencing costs
3）Available in multiple formats to suite different workflow needs - purified DNA & RNA, ctDNA, encapsulated ctDNA in plasma, and FFPE
4）Manufactured in cGMP-compliant, ISO 13485-certified facilities
5）Stringent product release testing - all variants qualified by dPCR for allele frequencies or copy numbers
| 参比物质 | 货号 | 规格 |
| Seraseq® Whole Transcriptome RNA Seq Mix | 0710-2129 | 1 x 20 µl |
| Seraseq® Unmethylated ctDNA Mutation Mix | 0710-3088 | 1 x 25 µl |
| Seraseq® Tumor Mutation DNA Mix v2 AF 7 HC | 0710-0095 | 1 x 25 µl |
| Seraseq® Tumor Mutation DNA Mix v2 AF 10 HC | 0710-0094 | 1 x 25 µl |
| Seraseq® Tri-Level Tumor Mutation DNA Mix v2 HC | 0710-0097 | 1 x 25 µl |
| Seraseq® TNA (DNA/RNA) WT Mix | 0710-1580 | 2 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +6 copies | 0710-2867 | 1 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +3 copies | 0710-2866 | 1 x 20 µl |
| Seraseq® Solid Tumor CNV Mix, +12 copies | 0710-2868 | 1 x 20 µl |
| Seraseq® NTRK Fusion RNA Mix | 0710-1696 | 1 x 20 µl |
| Seraseq® Myeloid Mutation DNA Mix | 0710-0408 | 1 x 25 µl |
| Seraseq® Myeloid Fusion RNA Mix | 0710-0407 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix WT | 0710-2646 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF1% | 0710-2649 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF0.5% | 0710-2648 | 1 x 25 µl |
| Seraseq Myeloid ctDNA Mix AF0.1% | 0710-2647 | 1 x 25 µl |
| Seraseq® MSI Reference Panel Mix AF5% | 0710-1675 | 2 x 15 µl |
| Seraseq® MSI Reference Panel Mix AF20% | 0710-1676 | 2 x 15 µl |
| Seraseq® Methylated ctDNA Mutation Mix | 0710-3089 | 1 x 25 µl |
| Seraseq® Lymphoma DNA Mutation Mix | 0710-2203 | 1 x 25 µl |
| Seraseq™ Lung & Brain CNV Mix, + 6 copies | 0710-0415 | 1 x 20 µl |
| Seraseq® Lung & Brain CNV Mix, + 3 copies | 0710-0414 | 1 x 20 µl |
| Seraseq® Lung & Brain CNV Mix, + 12 copies | 0710-0416 | 1 x 20 µl |
| Seraseq® HRD gDNA Negative Mix | 0710-2881 | 2 x 20 µl |
| Seraseq® HRD gDNA Low-Positive Mix | 0710-2880 | 2 x 20 µl |
| Seraseq® HRD gDNA High-Positive Mix | 0710-2879 | 2 x 20 µl |
| Seraseq® gDNA TMB Reference Panel Mix | 0710-2463 | 5 x 20 µl |
| Seraseq® gDNA TMB Mix Score 9 | 0710-1325 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 7 | 0710-1326 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 26 | 0710-1323 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 20 | 0710-1324 | 2 x 500 ng |
| Seraseq® gDNA TMB Mix Score 13 | 0710-1586 | 2 x 10 µl |
| Seraseq® gDNA MSI-High Mix | 0710-1670 | 1 x 20 µl |
| Seraseq® gDNA BRCA1/2 LGR Somatic Mutation Mix | 0730-0567 | 1 x 25 µl |
| Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix | 0730-0568 | 1 x 25 µl |
| Seraseq® Fusion RNA Mix v4 | 0710-0497 | 1 x 25 µl |
| Seraseq® FFPE WT (DNA/RNA) Reference Material | 0710-0137 | 1 x 10 µm |
| Seraseq® FFPE TMB RM Score 9 | 0710-1308 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 7 | 0710-1310 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 26 | 0710-1307 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 20 | 0710-1309 | 2 x 10 µm |
| Seraseq® FFPE TMB RM Score 13 | 0710-1618 | 2 x 10 um |
| Seraseq® FFPE Solid Tumor CNV Reference Materials | 0710-2865 | 1 x 10 µm |
| Seraseq® FFPE NTRK Fusion RNA Reference Material | 0710-1031 | 1 x 10 µm |
| Seraseq® FFPE MSI-High RM | 0710-2236 | 1 x 10 um |
| Seraseq® FFPE Lymphoma DNA Reference Material | 0710-2202 | 1 x 10 µm |
| Seraseq® FFPE HRD Negative RM | 0710-2644 | 1 x 10 µm |
| Seraseq® FFPE HRD Low-Positive RM | 0710-2645 | 1 x 10 µm |
| Seraseq® FFPE HRD High-Positive RM | 0710-2643 | 1 x 10 µm |
| Seraseq® FFPE Tumor Fusion RNA v4 Reference Material | 0710-0496 | 1 x 10 µm |
| Seraseq® FFPE BRCA1/2 LGR Reference Material | 0730-0564 | 1 x 10 µm |
| Seraseq® ctDNA Reference Material v2 WT | 0710-0208 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF2% | 0710-0203 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF1% | 0710-0204 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF0.5% | 0710-0205 | 1 x 5 mL |
| Seraseq® ctDNA Reference Material v2 AF0.125% | 0710-0207 | 1 x 5 mL |
| Seraseq® ctDNA Mutation Mix v2 WT | 0710-0144 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF2% | 0710-0139 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF1% | 0710-0140 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.5% | 0710-0141 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.25% | 0710-0142 | 1 x 25 µl |
| Seraseq® ctDNA Mutation Mix v2 AF0.125% | 0710-0143 | 1 x 25 µl |
| Seraseq® ctDNA MRD Panel Mix | 0710-2146 | 4 x 20 µl |
| Seraseq® ctDNA Complete™ Reference Material WT (0%) | 0710-0674 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF5% | 0710-0669 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF2.5% | 0710-0670 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF1% | 0710-0671 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF0.5% | 0710-0672 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Reference Material AF0.1% | 0710-0673 | 1 x 5 mL |
| Seraseq® ctDNA Complete™ Mutation Mix WT (0%) | 0710-0533 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF5% | 0710-0528 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF2.5% | 0710-0529 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF1% | 0710-0530 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF0.5% | 0710-0531 | 1 x 25 µl |
| Seraseq® ctDNA Complete™ Mutation Mix AF0.1% | 0710-0532 | 1 x 25 µl |
| Seraseq® Compromised FFPE WT (DNA/RNA) RM | 0710-1710 | 1 x 10 µm |
| Seraseq® Compromised FFPE Tumor DNA RM | 0710-1492 | 1 x 10 µm |
| Seraseq® Breast CNV Mix, + 6 copies | 0710-0412 | 1 x 20 µl |
| Seraseq® Breast CNV Mix, + 3 copies | 0710-0411 | 1 x 20 µl |
| Seraseq® Breast CNV Mix, + 12 copies | 0710-0413 | 1 x 20 µl |
| Seraseq® Blood TMB Mix Score 7 | 0710-2087 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 26 | 0710-2090 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 20 | 0710-2089 | 3 x 20 µl |
| Seraseq® Blood TMB Mix Score 13 | 0710-2088 | 3 x 20 µl |
| Seraseq® Turner Syndrome (XO) Reference Material | 0720-0952 | 1 x 1 mL |
| Seraseq® Trisomy 21 Male-Matched Reference Material | 0720-0167 | 1 x 1 mL |
| Seraseq® Trisomy 21 Female-Matched Reference Material | 0720-0168 | 1 x 1 mL |
| Seraseq® Trisomy 18 Male-Matched Reference Material | 0720-0171 | 1 x 1 mL |
| Seraseq® Trisomy 18 Female-Matched Reference Material | 0720-0172 | 1 x 1 mL |
| Seraseq® Trisomy 13 Male-Matched Reference Material | 0720-0779 | 1 x 1 mL |
| Seraseq® Trisomy 13 Female-Matched Reference Material | 0720-0780 | 1 x 1 mL |
| Seraseq® Triple X Syndrome (XXX) Reference Material | 0720-1069 | 1 x 1 mL |
| Seraseq® PGT-A Trisomy 21 Reference Material | 0720-0775 | 1 x 10 µl |
| Seraseq® PGT-A Trisomy 18 Reference Material | 0720-0776 | 1 x 10 µl |
| Seraseq® PGT-A Trisomy 13 Reference Material | 0720-0777 | 1 x 10 µl |
| Seraseq® PGT-A Euploid Reference Material | 0720-0778 | 1 x 10 µl |
| Seraseq® Klinefelter Syndrome (XXY) Reference Material | 0720-0953 | 1 x 1 mL |
| Seraseq® Jacobs Syndrome (XYY) Reference Material | 0720-0954 | 1 x 1 mL |
| Seraseq® Euploid Male-Matched Reference Material | 0720-0169 | 1 x 1 mL |
| Seraseq® Euploid Female-Matched Reference Material | 0720-0170 | 1 x 1 mL |
| Seraseq® 22q11 Male-Matched Reference Material | 0720-0173 | 1 x 1 mL |
| Seraseq® 22q11 Female-Matched Reference Material | 0720-0174 | 1 x 1 mL |
| Seraseq® Inherited Cancer DNA Mix v1 | 0730-0003 | 1 x 200 µL |
| Seraseq® gDNA BRCA1/2 LGR Inherited Mutation Mix | 0730-0568 | 1 x 25 µL |
| Seraseq® FFPE BRCA1/2 LGR Reference Material | 0730-0564 | 1 x 10 µm |
| Seraseq® Cardiomyopathy Reference Material | 0740-0021 | 1 x 200 µL |
艾美捷科技代理Arctizymes Technologies品牌酶制剂。
Arctizymes Technologies 是一家专注于酶技术和生物催化的公司，致力于为制药、化工、食品和环境保护等领域提供高效的酶解决方案。Arctizymes Technologies公司提供多种用于不同工业应用的酶制剂，包括水解酶、氧化还原酶、转移酶等；并根据客户需求，提供定制化的酶开发和优化服务。Arctizymes Technologies公司酶制剂应用领域包括：
（1）制药，广泛应用于药物合成、手性化合物制备等；
（2）化工，用于绿色化学工艺，减少环境污染；
（3）食品，用于食品加工、保鲜和品质改良；
（4）环境保护：用于废水处理、生物降解等环保应用。
<<<< " data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Arctizymes Technologies品牌酶制剂"> 艾美捷科技代理Arctizymes Technologies品牌酶制剂
艾美捷科技特价产品列表持续更新中，现货，超低折扣，欢迎咨询！
| 品名 | 货号 |
| S-(P-TOLYL) N-(3-(TRIFLUOROMETHYL)PHENYL)THIOLCARBAMATE | S6501 |
| Vegetable Peptone for Biotechnology and Microbiology | 16922 |
| Monoclonal Anti-Mouse Lambda Light Chains | L2280 |
| 铂(0)-2,4,6,8-四甲基-2,4,6,8-四乙烯基环四硅氧烷复合体 溶液 | 479543 |
| 4-（N-马来酰亚胺甲基）环己烷-1-羧酸3-磺基-N-羟基琥珀酰亚胺酯 钠盐 | M6035 |
| Amberlyst® 15 Ion Exchange Resin | 216380 |
| pH-indicator paper pH 5.5 - 9.0 | 1095640003 |
| 甲基全- 顺 -7,10,13,16,19-二十二碳五烯酸酯 | 17269 |
| β-烟酰胺腺嘌呤二核苷酸2′-磷酸，还原型 四钠盐 水合物 | N7505 |
| 2,2′-联氮双(3-乙基苯并噻唑啉-6-磺酸) 二铵盐 | A1888 |
| 杜氏改良Eagle 培养基/营养混合物 F-12 Ham | D8437-500ML |
| Adenosine 5′-triphosphate 镁盐 | A9187 |
| N-（3-二甲基氨基丙基）-N′-乙基碳二亚胺 盐酸盐 | 03450 |
| N-（3-二甲基氨基丙基）-N'-乙基碳二亚胺 盐酸盐 | 3449 |
| 乙二醇-双（2-氨基乙醚）-N,N,N′,N′-四乙酸 | E4378 |
| 乙二醇-双（2-氨基乙醚）-N,N,N′,N′-四乙酸 | E3889 |
| 2-二(2-羟乙基)氨基-2-羟甲基-1,3-丙二醇 | B4429 |
| 4-甲基伞形酮基-N-乙酰基-β-D-氨基葡萄糖苷 | M2133 |
| N,O-双(三甲基硅)三氟乙酰胺(含三甲基氯硅烷) | 15238 |
| 还原型 β-烟酰胺腺嘌呤二核苷酸 二钠盐 水合物 | N8129 |
| 3,3′-二硫代二丙酸二(N-羟基丁二酰亚胺酯) | D3669 |
| Nα-苯甲酰-DL-精氨酸 4-基苯酰胺 盐酸盐 | B4875 |
| 2-羟基-4′-(2-羟乙氧基)-2-甲基苯丙酮 | 410896 |
| 三（2,2′——联吡啶二氯钌 (II) 六水合物 | 544981 |
| 1-丁基-3-甲基咪唑双(三氟甲基磺酰)酰亚胺 | 711713 |
| Ionomycin calcium salt | I0634 |
| 4,5-亚甲二氧基-1,2-苯二胺 二盐酸盐 | D4784 |
| 5(6)-羧基二乙酸荧光素 N-琥珀酰亚胺酯 | 21888 |
| Kollisolv ® PEG E 400 | 06855 |
| 杜氏改良 Eagle 培养基 - 高葡萄糖 | D6546-500ML |
| 杜氏改良 Eagle 培养基 - 高葡萄糖 | D5671-500ML |
| 杜氏改良 Eagle 培养基 - 高葡萄糖 | D5796-500ML |
| 杜氏改良 Eagle 培养基 - 高葡萄糖 | D6429-500ML |
| 3,4-二乙氧基-3-环丁烯-1,2-二酮 | 31630 |
| 3,3′,5-三碘-L-甲状腺氨酸 钠盐 | T6397 |
| L -3,4-二羟基苯丙氨酸甲酯 盐酸盐 | D1507 |
| 酒石酸钠 二元 二水合物 二元 二水合物 | S4797 |
| N-甲基-N-（三甲基硅烷基）三氟乙酰胺 | 69479 |
| 脂多糖 来源于大肠杆菌 0127:B8 | L4516 |
| 3,3-二氨基联苯胺 四盐酸盐 水合物 | D5637 |
| 反式-1,2-环己二胺四乙酸 一水合物 | 319945 |
| 卡那霉素 硫酸酯 来源于卡那霉素链霉菌 | E004000 |
| 杜氏改良 Eagle 培养基-低葡萄糖 | D6046-500ML |
| 脂多糖 来源于大肠杆菌 0111:B4 | L2630 |
| 1,1,1,3,3,3-六氟-2-丙醇 | 105228 |
| 脂多糖 来源于大肠杆菌 0111:B4 | L4391 |
| 2-羟基-2-甲基-1-苯基-1-丙酮 | 405655 |
| 3,3′,5-三碘代-L-甲状腺原氨酸 | T2877 |
| 嘌呤霉素 二盐酸盐 来源于白色链球菌 | P8833 |
| 双苯并咪唑 H 33342 三盐酸盐 | B2261 |
| 4-硝基苯基磷酸盐 二钠盐 六水合物 | 71768 |
| 2,6-二- 叔-丁基-4-甲基苯酚 | 34750 |
| 1,4-二叠氮双环[2.2.2]辛烷 | D27802 |
| 脂多糖 来源于肠沙门氏菌 肠道血清型 | L6143 |
| 脂多糖 来源于大肠杆菌 055:B5 | L6529 |
| 脂多糖 来源于大肠杆菌 055:B5 | L2880 |
| 脱氧核糖核酸，单链 来源于鲑鱼睾丸 | D7656 |
| 黄素腺嘌呤二核苷酸 二钠盐 水合物 | F8384 |
| 脱氧核糖核酸 钠盐 来源于小牛胸腺 | D1501 |
| 蛋白酶 K 来源于林伯氏白色念球菌 | 539480 |
| 三 2-羰基乙基 磷盐酸盐 盐酸盐 | 75259 |
| 异丙基β-D-1-硫代吡喃半乳糖苷 | I5502 |
| 蛋白酶 K 来源于林伯氏白色念球菌 | P2308 |
| 腺苷 5'-三磷酸 二钠盐 水合物 | A2383 |
| 脱氧核糖核酸酶 I 来源于牛胰腺 | DN25 |
| 三 2-羰基乙基 磷盐酸盐 盐酸盐 | C4706 |
| pH指示纸pH 1-14通用指示剂 | 1109620003 |
| 蛋白酶 K 来源于林伯氏白色念球菌 | P6556 |
| 脱氧核糖核酸 钠盐 来源于鲑鱼睾丸 | D1626 |
| Thrombin 来源于人类血浆 | T7572 |
| OptiPrep™密度梯度培养基 | D1556 |
| Triton™ X-405 溶液 | X405 |
| Thrombin 来源于人类血浆 | T6884 |
| D- (+)-氨基葡萄糖 盐酸盐 | G4875 |
| D- (+)-氨基葡萄糖 盐酸盐 | G1514 |
| 脱氧核糖核酸酶 I 来源于牛胰腺 | D5025 |
| 硫酸软骨素A 钠盐 来源于牛气管 | C9819 |
| β-甘油磷酸盐 二钠盐 五水合物 | 50020 |
| D-(+)-半乳糖醛酸 一水合物 | 48280 |
| 丙烯酰胺双丙烯酰胺，30％ 溶液 | A3574 |
| 聚（二烯丙基二甲基氯化铵） 溶液 | 409014 |
| N -乙酰基- D -氨基葡萄糖 | A8625 |
| Z-Leu-Leu-Leu-al | C2211 |
| 普鲁兰多糖(Pullulan) | P4516 |
| β-甘油磷酸盐 二钠盐 水合物 | G9422 |
| 核糖核酸，转移 来源于大肠杆菌 | R1753 |
| 4-硝基苯基 β-D-葡糖苷酸 | N1627 |
| 乙二胺四乙酸 二钠盐 二水合物 | E5134 |
| Pluronic® F-127 | P2443 |
| 马尿酰-组氨酰-亮氨酸 水合物 | H1635 |
| 马尿酰-组氨酰-亮氨酸 水合物 | 859052 |
| OXONE®，单过硫酸盐化合物 | 228036 |
| 208272 -氯化钒(III | 208272 |
| α-淀粉酶 来源于枯草芽孢杆菌 | 10070 |
| 2',7'-二氯荧光素二乙酸酯 | D6883 |
| D -(+)-麦芽糖 一水合物 | M5885 |
| 硫酸软骨素 钠盐 来源于牛软骨 | C6737 |
| 5 (6)-羧基荧光素二乙酸酯 | 21879 |
| 4-(4-甲氧苯基)-2-丁酮 | M19600 |
| L-组氨酸 单盐酸盐 一水合物 | H8125 |
| 鸟苷5′-三磷酸 钠盐 水合物 | V900868 |
| Fmoc-tBu-Gly-OH | 47524 |
| 2'-羟基-4'-甲氧基苯乙酮 | H35803 |
| 双氢氧化乙二胺铜(II) 溶液 | 442305 |
| 吐温80(TWEEN® 80) | P4780 |
| Taka 淀粉酶 来源于米曲霉 | 86247 |
| D -(+)-海藻糖 二水合物 | V900932 |
| D-(+)-海藻糖 二水合物 | T9531 |
| D-(+)-海藻糖 二水合物 | T0167 |
| D-(+)-海藻糖 二水合物 | T5251 |
| 淀粉葡萄糖苷酶 来源于黑曲霉 | 10115 |
| 表皮生长因子 来源于鼠颔下腺 | E4127 |
| Ficoll® PM 400 | F4375 |
| IGEPAL® CA-630 | I8896 |
| 双(三氟甲烷)磺酰亚胺 锂盐 | 15224 |
| D-(+)-棉子糖 五水合物 | R0250 |
| 聚(乙烯-co-乙酸乙烯酯) | 340502 |
| IGEPAL® CO-520 | 238643 |
| 磷酸二氢钠二水合物 二水合物 | V900328 |
| 2,3,5-氯化三苯基四氮唑 | T8877 |
| 壮观霉素 二盐酸盐 五水合物 | S9007 |
| 铁氰化钾 (II) 三水合物 | P3289 |
| 磷酸二氢钠二水合物 二水合物 | 71505 |
| 邻苯二甲酸二(2-乙基己)酯 | 36735 |
| Iscove 改良杜氏培养基 | I3390-500ML |
| 营养混合物 F-12 Ham | N6658-500ML |
| 氯化十六烷基吡啶翁 一水合物 | C9002 |
| 1α,25-二羟基维生素D3 | D1530 |
| Gelzan™ CM 结冷胶 | G1910 |
| (3-巯基丙基)三甲氧基硅烷 | 175617 |
| 固蓝BB盐 半(氯化锌) 盐 | 44670 |
| 黑芥子硫苷酸钾水合物 水合物 | 85440 |
| 3-氨基苯甲酸乙酯 甲磺酸盐 | A5040 |
| 3-异丁基-1-甲基黄嘌呤 | I5879 |
| 牛血清白蛋白 来源于牛血清 | SRE0096 |
| 中性红溶液 (0.33%) | N2889 |
| 白蛋白 溶液 来源于牛血清 | A1595 |
| 异丙基β-D-硫代半乳糖苷 | V900917 |
| 蛋白酶 来源于地衣芽孢杆菌 | P5380 |
| 明胶 来源于冷水鱼类的皮肤 | G7041 |
| IV型胶原酶，Cls IV | C4-BIOC |
| 牛血清白蛋白 来源于牛血清 | A9418 |
| 三甲醇丙烷乙氧酯三丙烯酸酯 | 409073 |
| 1,4-丁二醇二缩水甘油醚 | 220892 |
| 肝素 钠盐 来源于猪肠粘膜 | H3149 |
| L-谷氨酸 单钠盐 水合物 | G1626 |
| 牛血清白蛋白 来源于牛血清 | A1933 |
| 纤维蛋白原 来源于人类血浆 | F4883 |
| 纤维蛋白原 来源于人类血浆 | F3879 |
| 邻苯二甲酸二丁酯（驱蚊叮） | 36736 |
| RPMI-1640 培养基 | R8758-500ML |
| RPMI-1640 培养基 | R5886-500ML |
| N,N′-二环己基碳二亚胺 | D80002 |
| Triton™ X-114 | X114 |
| 4-羟基-3-甲氧基肉桂醛 | 382051 |
| 潮霉素B 来源于吸水链霉菌 | V900372 |
| 3-异丁基-1-甲基黄嘌呤 | I7018 |
| 氯化铁(III) 六水合物 | 44944 |
| Triton™ X-100 | V900502 |
| 乙二胺四乙酸 二钠盐 溶液 | E7889 |
| 乙二胺四乙酸 二钠盐 溶液 | 3690 |
| 牛血清白蛋白 来源于牛血清 | A3059 |
| 牛血清白蛋白 来源于牛血清 | A7030 |
| Tyrphostin 25 | T7290 |
| IV型胶原酶，Cls IV | C4BIOC |
| Triton™ X-100 | T8787 |
| Triton™ X-100 | T9284 |
| 蛋白酶 来源于灰色链霉菌 | P8811 |
| 透明质酸酶 来源于牛睾丸 | H3506 |
| 1,1-二甲双胍 盐酸盐 | D150959 |
| 胰蛋白酶-EDTA 溶液 | T4049 |
| 胶原酶 来源于溶组织梭菌 | C9407 |
| 弹性蛋白酶 来源于猪胰腺 | E7885 |
| N -月桂酰肌氨酸 钠盐 | L5125 |
| 磷酸钠 二元 十二水合物 | V900268 |
| 弹性蛋白酶 来源于猪胰腺 | E1250 |
| Brij® L23 溶液 | B4184 |
| 2-顺式,4-反式脱落酸 | 862169 |
| 6-羟基多巴胺 氢溴酸盐 | 162957 |
| 新霉素 三硫酸盐 水合物 | N6386 |
| N-乙酰基-L-半胱氨酸 | A9165 |
| 过氧化氢酶 来源于牛肝脏 | C9322 |
| 磷酸肌酸 二钠盐 水合物 | P7936 |
| 胃蛋白酶 来源于猪胃粘膜 | P7012 |
| 氯化铜(II) 二水合物 | 307483 |
| Eagle最低必需培养基 | M4655-500ML |
| ProClin™ 300 | 48912-U |
| 363081- 聚乙烯醇 | 363081 |
| 乙酰基-β-氯化甲基胆碱 | A2251 |
| 酪蛋白 钠盐 来源于牛奶 | C8654 |
| 氧化钴 (II,III) | 637025 |
| 萘酚 AS-MX 磷酸盐 | N4875 |
| 蛋白酶 来源于灰色链霉菌 | P5147 |
| 荧光素异硫氰酸酯异构体I | F7250 |
| ProClin™ 300 | 48915-U |
| ProClin™ 300 | 48918-U |
| ProClin™ 300 | 48917-U |
| ProClin™ 300 | 48914-U |
| DL-二硫代苏糖醇 溶液 | 43816 |
| 胶原酶 来源于溶组织梭菌 | C2139 |
| 胶原酶 来源于溶组织梭菌 | C6885 |
| Mowiol® 4-98 | 81382 |
| 胃蛋白酶 来源于猪胃粘膜 | P7000 |
| Y-27632 二盐酸盐 | Y0503 |
| L - (−) -葡萄糖 | G5500 |
| 胶原酶 来源于溶组织梭菌 | C9891 |
| 氯化锡(II) 二水合物 | 474762 |
| Trizma® 盐酸盐 | 93363 |
| Trizma® 盐酸盐 | T5941 |
| Trizma® 盐酸盐 | T6666 |
| Trizma® 盐酸盐 | V900312 |
| 磷酸钠 一元 一水合物 | S9638 |
| p-甲苯磺酸 一水合物 | 402885 |
| Trizma® 盐酸盐 | T3253 |
| 2′,3′-二脱氧胞苷 | D5782 |
| 聚(乙二醇)二丙烯酸酯 | 437441 |
| 聚(乙二醇)二丙烯酸酯 | 475629 |
| 异硫氰酸胍水溶液 溶液 | 50983 |
| 6-羟基多巴胺 盐酸盐 | H4381 |
| 弗氏不完全佐剂，改良型 | 344291 |
| 胰蛋白酶 来源于牛胰腺 | T8802 |
| 胰蛋白酶 来源于牛胰腺 | T1426 |
| 三(羟甲基)甲基甘氨酸 | T0377 |
| 白花丹素 来源于紫雪花 | P7262 |
| 褐藻糖胶 来源于墨角藻 | F8190 |
| 重组人表皮细胞生长因子 | E9644 |
| N-乙酰-d-半乳糖胺 | A2795 |
| 白蛋白 来源于人类血清 | A1653 |
| N,N-二甲基丙烯酰胺 | 274135 |
| (R)-(+)-柠檬烯 | 62118 |
| 1,3-二甲基巴比妥酸 | 39565 |
| 1,2,3,4-四氢萘 | 429325 |
| 1,2,3,4-四氢萘 | A2754 |
| 过氧化物酶 来源于辣根 | P6782 |
| 2-甲基吡啶硼烷复合物 | 654213 |
| 白蛋白，生物素标记 牛 | A8549 |
| 盐酸多西环素，现成溶液 | D3072 |
| 5-溴-2′-脱氧尿苷 | B5002 |
| 胰脂肪酶 来源于猪胰腺 | P1750 |
| (−)-四咪唑 盐酸盐 | L9756 |
| ProClin 200 | 48171-U |
| D -葡萄糖酸 钠盐 | G9005 |
| 凝血酶 来源于牛血浆 | T4648 |
| N,N-二甲基甲酰胺 | 319937 |
| N,N-二甲基甲酰胺 | 270547 |
| 5-羟甲基-2-糠醛 | H40807 |
| 6-（二甲氨基）嘌呤 | D2629 |
| 白蛋白 来源于鸡蛋白 | A5378 |
| 2,2,2-三溴乙醇 | T48402 |
| Trizma ® 碱 | T6066 |
| 盐酸硫胺素 (B1) | 47858 |
| 三氟化硼-甲醇 溶液 | B1252 |
| 5-氟乳清酸 水合物 | F5013 |
| 2,4-二氯苯氧乙酸 | D7299 |
| 2,4-二氯苯氧乙酸 | D70724 |
| N -乙基马来酰亚胺 | 04259 |
| L -还原型谷胱甘肽 | V900456 |
| D -(+)-葡萄糖 | G7528 |
| D -(+)-半乳糖 | G5388 |
| Trizma ® 碱 | V900483 |
| 四氢噻吩 1-氧化物 | T22403 |
| TWEEN ® 80 | P1754 |
| 4-甲基伞形酮磷酸酯 | M8883 |
| L-蛋氨酸亚砜酰亚胺 | M5379 |
| L-赖氨酸 一水合物 | L9037 |
| 异丙肾上腺素 盐酸盐 | I5627 |
| 抗坏血酸6-棕榈酸酯 | A1968 |
| 十六烷基三甲基氯化铵 | 52366 |
| N,N-二甲基乙酰胺 | 38840 |
| D -(+)-葡萄糖 | G7021 |
| 4-(二甲氨基)吡啶 | 107700 |
| TWEEN ® 20 | P2287 |
| TWEEN ® 20 | P9416 |
| N,N-二甲基甲酰胺 | 227056 |
| L -还原型谷胱甘肽 | G4251 |
| Stains-All | E9379 |
| 白蛋白 来源于鸡蛋白 | A5503 |
| 四甲基氢氧化铵 溶液 | 328251 |
| 1,2-二甲氧基乙烷 | E27408 |
| D -(+)-半乳糖 | G0750 |
| TWEEN ® 20 | P1379 |
| 1,2,4-三甲基苯 | T73601 |
| 溴化十四烷基三甲基铵 | T4762 |
| D -(+)-半乳糖 | V900922 |
| L-(+)-阿拉伯糖 | V900920 |
| 3,4-二羟基苯甲酸 | 37580 |
| D -(+)-葡萄糖 | G8270 |
| D -(+)-葡萄糖 | G5767 |
| 脂肪酶 来源于猪胰腺 | L3126 |
| 聚乙二醇甲醚丙烯酸酯 | 454990 |
| 活性硅酸镁, 硅酸镁 | 220736 |
| 四丁基氢氧化铵 溶液 | 178780 |
| 5-胆甾烯-3-酮 | C75004 |
| N-苯基-1-萘胺 | 104043 |
| 二亚苯基碘鎓氯化物 | D2926 |
| 盐酸多巴胺 盐酸盐 | H8502 |
| CHIR99021 | SML1046 |
| 5-(羟甲基)糠醛 | W501808 |
| L-α-磷脂酰胆碱 | V900485 |
| (±)-α-生育酚 | T3251 |
| 淀粉 来源于马铃薯 | S4251 |
| L-α-磷脂酰胆碱 | P7443 |
| L-α-磷脂酰胆碱 | P5394 |
| L-α-磷脂酰胆碱 | P3556 |
| (R)-MG132 | M8699 |
| 溴化十六烷基三甲铵 | H9151 |
| 溴化十六烷基三甲铵 | H6269 |
| D- (-)-果糖 | F3510 |
| DOTAP 氯化物 | D6182 |
| 环磷酰胺 一水合物 | C0768 |
| 奎诺二甲基丙烯酸酯 | 238813 |
| 明胶 来源于猪皮肤 | 48722-100G-F |
| 5-胆甾烯-3-酮 | F8630 |
| 汉克斯平衡盐 溶液 | H6648-500ML |
| 汉克斯平衡盐 溶液 | H8264-500ML |
| 杜氏磷酸盐缓冲盐水 | D8662-500ML |
| 杜氏磷酸盐缓冲盐水 | D1408-500ML |
| 杜氏磷酸盐缓冲盐水 | D8537-500ML |
| 血管紧张素II，人 | A9525 |
| 2,3-丁二酮一肟 | B0753 |
| 羧甲基纤维素 钠盐 | C5013 |
| 酪蛋白 来源于牛奶 | C5890 |
| N -乙基马来酰亚 | E3876 |
| D- (-)-果糖 | F0127 |
| HC-030031 | H4415 |
| Phytagel™ | P8169 |
| 淀粉 来源于马铃薯 | S5651 |
| 羧甲基纤维素 钠盐 | C5678 |
| 羧甲基纤维素 钠盐 | C4888 |
| 羧甲基纤维素 钠盐 | 21902 |
| 明胶 来源于猪皮肤 | 48722 |
| 2-甲基-2-丁醇 | 240486 |
| 明胶 来源于猪皮肤 | V900863 |
| α-乳糖 一水合物 | L3625 |
| 1-氨基环丙烷羧酸 | A3903 |
| 明胶 来源于猪皮肤 | G2500 |
| 酚妥拉明 甲磺酸盐 | P7561 |
| D- (-)-果糖 | F2543 |
| D-2-脱氧葡萄糖 | D8375 |
| D-(-)-水杨苷 | S0625 |
| MES 一水合物 | 69892 |
| 十二烷基苯磺酸钠 | 289957 |
| Percoll® | P4937 |
| 钨酸钠 二水合物 | 223336 |
| 钨酸钠 二水合物 | 72069 |
| 胰岛素 溶液 人 | I9278 |
| 硫酸镁 七水合物 | M2773 |
| 双环己酮草酰二腙 | C9012 |
| 胍 盐酸盐 溶液 | G9284 |
| 阿尔新蓝 8GX | A3157 |
| 甲基乙二醛 溶液 | M0252 |
| 甜菜碱 一水合物 | 14300 |
| 明胶 来源于牛皮 | G9391 |
| MES 一水合物 | V900336 |
| 氯化镁 六水合物 | V900020 |
| 硫酸镁 七水合物 | M1880 |
| 乙酸镁 四水合物 | M0631 |
| DL-二硫苏糖醇 | D9779 |
| 白蛋白，二硝基苯 | A6661 |
| 碘代硫代乙酰胆碱 | A5751 |
| 聚乙烯亚胺，线性 | 765090 |
| 聚乙烯亚胺，线性 | 764604 |
| 聚乙烯亚胺，线性 | 764582 |
| 硫酸铜 五水合物 | 469130 |
| 氯化镁 六水合物 | M2670 |
| 2-氨基苯甲酰胺 | A89804 |
| DL-二硫苏糖醇 | V900830 |
| 氯化镁 六水合物 | M9272 |
| 氯化钙 二水合物 | C7902 |
| 核黄素 (B2) | 47861 |
| 甲萘醌 (K3) | 47775 |
| Percoll® | P1644 |
| 硫酸铜 五水合物 | 209198 |
| 氯化钴 六水合物 | 255599 |
| 氯化钡 二水合物 | 217565 |
| 1,2-二氯乙烷 | E27408 |
| DL-二硫苏糖醇 | D0632 |
| 2,3-二氨基萘 | 88461 |
| 柠檬酸 一水合物 | C1909 |
| 聚乙烯亚胺 溶液 | P3143 |
| 硼烷二甲胺络合物 | 180238 |
| 25-羟基胆甾醇 | H1015 |
| DL-二硫苏糖醇 | D9163 |
| Tris 乙磺酸 | T1375 |
| 硫酸锰 一水合物 | 221287 |
| 氧化铱(IV) | 206237 |
| Isomalt | PHR1769 |
| 聚乙烯吡咯烷酮 | PVP360 |
| 丙酮酸钠 溶液 | S8636 |
| 氢氧化钾 溶液 | 67109 |
| 氢氧化铵 溶液 | 338818 |
| 十二烷基硫酸钠 | L3771 |
| 4-氨基苯甲酸 | A9878 |
| 5-氨基水杨酸 | A3537 |
| MES 水合物 | V900381 |
| 四乙二醇二甲醚 | 172405 |
| 丁基羟基茴香醚 | B1253 |
| 氧化钛（IV） | 14021 |
| 氢氧化铯 溶液 | 232041 |
| 氯化铜(II) | 222011 |
| 盐酸胍 盐酸盐 | V900385 |
| 氯化铜(II) | 751944 |
| 氯化镍(II) | 339350 |
| 2-氨基异丁酸 | 850993 |
| 高效氯氟氰菊酯 | 31058 |
| L -抗坏血酸 | A92902 |
| 肉豆蔻酸异丙酯 | 172472 |
| 3-吗啉丙磺酸 | M1254 |
| 聚乙烯吡咯烷酮 | P5288 |
| DL-半胱氨酸 | 861677 |
| 碘化铅(II) | 554359 |
| 碘化铅(II) | 398853 |
| 十二烷基硫酸钠 | V900859 |
| 肉豆蔻酸异丙酯 | V900558 |
| 二十三烷酸甲酯 | T9900 |
| 甘油三月桂酸酯 | T4891 |
| 碘化丙啶 溶液 | P4864 |
| 十二烷基硫酸钠 | L5750 |
| 氯喹 二磷酸盐 | C6628 |
| 2,3-丁二酮 | B85307 |
| PFO-DBT | 754013 |
| 十二烷基硫酸钠 | 436143 |
| 氢氧化钾 溶液 | 417661 |
| 甲氧胺 盐酸盐 | 226904 |
| 5-羟甲基糠醛 | 53407 |
| 氨苄西林 钠盐 | A9518 |
| A 83-01 | SML0788 |
| L -抗坏血酸 | 255564 |
| L -抗坏血酸 | A5960 |
| 氯化高铁血红素 | 51280 |
| poly(A) | P9403 |
| 培养基 199 | M4530-500ML |
| L -抗坏血酸 | 795437 |
| d-脱硫生物素 | D1411 |
| 弗氏不完全佐剂 | F5506 |
| 羧甲纤维素 钠 | C9481 |
| 羧甲基纤维素钠 | 419303 |
| 羧甲基纤维素钠 | 419273 |
| 消泡剂 204 | A6426 |
| 三氯乙酸 溶液 | T0699 |
| 聚乙烯吡咯烷酮 | V900010 |
| 聚乙烯吡咯烷酮 | V900008 |
| 胆固醇、植物的 | C1231 |
| 丁基羟基茴香醚 | 78943 |
| L -抗坏血酸 | 47863 |
| 阿霉素 盐酸盐 | D1515 |
| L -抗坏血酸 | A4544 |
| 吡啶-3-硼酸 | 512125 |
| 桑色素 水合物 | M4008 |
| 邻苯二甲酸氢钾 | 179922 |
| (−)-核黄素 | R9504 |
| 二叔丁基氯化膦 | 301558 |
| 氯化锡(II) | 208256 |
| 次氯酸钠 溶液 | 239305 |
| D -甘露醇 | M9647 |
| 十二烷基硫酸锂 | L9781 |
| 葡萄球菌溶菌素 | L7386 |
| 1,2-丙二醇 | 134368 |
| 组胺 二盐酸盐 | 53300 |
| D -甘露醇 | 63560 |
| 戊二醛 溶液 | G6403 |
| 磷酸钠 二元 | S9763 |
| 亚氨基二乙酸 | 220000 |
| 氯化钠 溶液 | S6546 |
| L-谷氨酰胺 | G8540 |
| 柳氮磺胺吡啶 | S0883 |
| 前列腺素E2 | P0409 |
| 1-硫代甘油 | M6145 |
| L-犬尿氨酸 | K8625 |
| 氯化镁 溶液 | 63069 |
| 氯化钙 溶液 | 21115 |
| 磷酸钠 一元 | S3139 |
| 乙二胺四乙酸 | E6758 |
| 乙二胺四乙酸 | E9884 |
| 磷酸钾 一元 | P0662 |
| 氯化铌(V) | 215791 |
| 叔丁基甲基醚 | 34875 |
| L-正亮氨酸 | N6877 |
| 对氨基苯胂酸 | A9258 |
| β-胡萝卜素 | C4582 |
| 磷酸钾 一元 | P5655 |
| 聚（乙二醇） | V900156 |
| D -甘露醇 | M1902 |
| 磷酸钠 二元 | V900061 |
| 四甲基乙二胺 | T7024 |
| 牛血清白蛋白 | SRE0098 |
| 磷酸钠 二元 | S5136 |
| D -丝氨酸 | S4250 |
| 次氮基三乙酸 | N9877 |
| 氯化锂 溶液 | L7026 |
| 3-吲哚乙酸 | I2886 |
| 血红蛋白 人 | H7379 |
| 聚（乙二醇） | 435465 |
| 山梨酸 钾盐 | 359769 |
| 羟胺 盐酸盐 | 159417 |
| 聚（乙二醇） | 95904 |
| 聚（乙二醇） | 81255 |
| 磷酸钾 一元 | 60229 |
| 3-吲哚乙酸 | 45533 |
| 环己基环己烷 | D79403 |
| 2-巯基苯并 | M3302 |
| 苯并[a]芘 | B1760 |
| 2-巯基乙醇 | M3148 |
| L-甲硫氨酸 | 64319 |
| D -山梨醇 | 85529 |
| 戊二醛 溶液 | 340855 |
| IR-820 | 543365 |
| L-天冬酰胺 | A4159 |
| 氯化乙酰胆碱 | A6625 |
| 牛血清白蛋白 | B2064 |
| 戊二醛 溶液 | G5882 |
| 戊二醛 溶液 | G7651 |
| 丙戊酸 钠盐 | P4543 |
| 曲古抑菌素A | V900931 |
| 台盼蓝 溶液 | T8154 |
| 聚（乙二醇） | P2139 |
| α-酮戊二酸 | 75890 |
| 弗氏完全佐剂 | F5881 |
| 视黄醇乙酸酯 | 46958 |
| 聚（乙二醇） | 81240 |
| D -甘露醇 | M4125 |
| 牛血清白蛋白 | V900933 |
| ι--卡拉胶 | C1138 |
| 三乙酸纤维素 | 22199 |
| 戊二醛 溶液 | G6257 |
| 5-阿扎胞苷 | A2385 |
| 氢氧化钠溶液 | 43617 |
| 2-巯基乙醇 | 63689 |
| 环庚三烯酚酮 | T89702 |
| L-甲硫氨酸 | M5308 |
| 聚（乙二醇） | 87333 |
| 硫胺 盐酸盐 | PHR1037 |
| 氯代二苯基膦 | C39601 |
| 1-甲基咪唑 | M50834 |
| 聚（乙二醇） | 89510 |
| γ-氨基丁酸 | A5835 |
| L-半胱氨酸 | 30089 |
| 三辛酸甘油酯 | T9126 |
| 2-巯基乙醇 | M6250 |
| L-半胱氨酸 | C7352 |
| 磷酸钠 一元 | S0751 |
| 氯化四唑氮蓝 | N6876 |
| 无水碳酸钠 | 451614 |
| 尿酸 钠盐 | U2875 |
| 二甲基亚砜 | 34869 |
| 甲醛 溶液 | 252549 |
| 硫代乙醇酸 | 528056 |
| L-色氨酸 | T8941 |
| 三羟丙基膦 | 777854 |
| 犬尿喹啉酸 | K3375 |
| 月桂酸甲酯 | 234591 |
| 过二硫酸钾 | 60489 |
| L-精氨酸 | A5006 |
| 苯甲磺酰氟 | 78830 |
| HEPES | H4034 |
| 酸性蓝90 | 27815 |
| 甲基嘧硫磷 | 32058 |
| 甲基纤维素 | M7027 |
| 十八烷基胺 | 305391 |
| 4-碘苯胺 | 129364 |
| 甲醛 溶液 | F1635 |
| L-组氨酸 | V900459 |
| 苯甲磺酰氟 | P7626 |
| β-雌二醇 | E8875 |
| 二甲基亚砜 | D2438 |
| 羟胺 溶液 | 438227 |
| L-乳酸钠 | 71718 |
| 脱氧胆酸钠 | 30970 |
| 偏高碘酸钠 | S1878 |
| 二甲基亚砜 | D5879 |
| 放线菌素D | A4262 |
| 高良姜黄素 | 92342 |
| 胰岛素 人 | I0908 |
| 甲基纤维素 | M0512 |
| 醋酸苯乙酯 | 290580 |
| β-香茅醇 | C83201 |
| 二甲基亚砜 | D4540 |
| 厄尔平衡盐 | E2888-500ML |
| L-组氨酸 | 53319 |
| 二甲基亚砜 | D8418 |
| β-雌二醇 | E2758 |
| L-色氨酸 | T0254 |
| L-酪氨酸 | T3754 |
| L-酪氨酸 | T8566 |
| 脱氧胆酸钠 | V900388 |
| 脱氧胆酸钠 | D6750 |
| 2,4-滴 | 31518 |
| 聚丙烯酰胺 | 749222 |
| 二甲基亚砜 | D2650 |
| 无水碳酸钠 | S7795 |
| 乙氧基喹啉 | 31519 |
| 五氧化二钒 | 221899 |
| 2,4-D | 49083 |
| 磷酸二氢铵 | 216003 |
| 1-溴辛烷 | 152951 |
| 1-十四醇 | 185388 |
| β-谷甾醇 | S1270 |
| 3-溴吡啶 | B80208 |
| L-丙氨酸 | A7627 |
| L-苹果酸 | M6413 |
| 茉莉酸甲酯 | 392707 |
| 二甲基亚砜 | 41639 |
| HEPES | V900477 |
| HEPES | H3375 |
| 酵母提取物 | Y1625 |
| 甲醛 溶液 | F8775 |
| CHAPS | V900480 |
| 毛地黄皂苷 | D5628 |
| 羟胺 溶液 | 467804 |
| 次黄嘌呤 | H9377 |
| 三氟乙酸 | 91707 |
| 过硫酸铵 | 248614 |
| 过硫酸铵 | A7460 |
| 碳酸氢钾 | 237205 |
| 乙酸丁酯 | 73285 |
| 乙酸乙酯 | 650528 |
| 碘海醇™ | D2158 |
| 过硫酸铵 | A3678 |
| 吲哚美辛 | 17378 |
| 罗格列酮 | R2408 |
| 乙酸乙酯 | 270989 |
| 1-丙醇 | 34871 |
| 氢氧化钠 | 221465 |
| 三氟乙酸 | 299537 |
| 多聚甲醛 | 441244 |
| 碳酸氢钾 | 60339 |
| 氢氧化钾 | 484016 |
| 氯化胆碱 | C7527 |
| 对苯二酚 | H9003 |
| 2-丙醇 | 34863 |
| 甲磺酸铯 | C1426 |
| 氯化亚铁 | 372870 |
| 二氯化钴 | 232696 |
| 丙烯酸钠 | 408220 |
| TAPS | T9659 |
| 柠檬酸铁 | F3388 |
| 链脲菌素 | V900890 |
| 氢氧化铝 | V900163 |
| 甲氧苄啶 | T7883 |
| 链脲菌素 | S0130 |
| 聚乙烯醇 | P8136 |
| 多聚甲醛 | P6148 |
| 氢氧化钾 | P5958 |
| 丙酮酸钠 | P2256 |
| 草氨酸钠 | O2751 |
| IPTG | I6758 |
| 秋水仙碱 | C3915 |
| 苯扎氯铵 | B6295 |
| 聚丙烯酸 | 323667 |
| 氢氧化钾 | 306568 |
| 2-丙醇 | 278475 |
| 氢氧化钾 | 221473 |
| 过硫酸钾 | 216224 |
| 2-丙醇 | 190764 |
| 四氢嘧啶 | 81619 |
| D-泛醇 | 76200 |
| 油酸甲酯 | 75160 |
| 四氢呋喃 | 34865 |
| 环己甲醇 | C105805 |
| 依托泊苷 | E1383 |
| 碘化丙啶 | P4170 |
| 吲哚美辛 | I7378 |
| 氢氧化铝 | 239186 |
| 棕榈酸钠 | P9767 |
| 三乙基胺 | 90335 |
| 双酚 A | 133027 |
| 红景天苷 | 43866 |
| 次黄嘌呤 | H9636 |
| 碘乙酰胺 | V900335 |
| 丁羟甲苯 | W218405 |
| 碳酸氢钠 | S4019 |
| 二氯乙酸 | D54702 |
| 三氯乙酸 | T6399 |
| 三氯乙酸 | T9159 |
| 三氯乙酸 | T4885 |
| 三氯乙酸 | T8657 |
| 角叉菜胶 | C1013 |
| 胆钙化醇 | PHR1237 |
| 1-氯萘 | 185752 |
| 地塞米松 | D4902 |
| 卵清蛋白 | S7951 |
| 碘乙酰胺 | I1149 |
| 麝香草酚 | T0501 |
| 伊文思蓝 | E2129 |
| 碘乙酰胺 | A3221 |
| 碳酸氢铵 | A6141 |
| 普瑞巴林 | Y0001805 |
| 米非司酮 | M8046 |
| 对氟碘苯 | 219428 |
| 碳酸氢钠 | V900182 |
| 三氟乙酸 | 302031 |
| 胰蛋白胨 | T7293 |
| 三氟乙酸 | T6508 |
| 泰莫西芬 | T5648 |
| 碳酸氢钠 | S5761 |
| 三乙醇胺 | V900257 |
| 胰蛋白胨 | T9410 |
| 巯基乙酸 | T3758 |
| 磺胺嘧啶 | S8626 |
| 二乙醇胺 | D8885 |
| 甲酰胺 | F7503 |
| 苯甲醇 | 24122 |
| 核糖醇 | A5502 |
| 棕榈酸 | P5585 |
| 壳聚糖 | 419419 |
| 壳聚糖 | 448877 |
| 二甲苯 | 534056 |
| 纯乙醇 | 459836 |
| 乙二醇 | 324558 |
| 半胱胺 | M9768 |
| 甲酸铵 | 516961 |
| 甜菜碱 | B2629 |
| 硫酸铵 | V900034 |
| 碘化钠 | 217638 |
| 乙二醇 | 102466 |
| 甘氨酸 | 33226 |
| 吡哆素 | P5669 |
| 正己醛 | 115606 |
| 酒石黄 | T0388 |
| 壳聚糖 | 448869 |
| 矿物油 | M8410 |
| 油红O | O0625 |
| 甘氨酸 | G7126 |
| 氯化镁 | M8266 |
| 环己烷 | 227048 |
| 异丙胺 | 471291 |
| 碘化钾 | 207969 |
| 碘化钾 | 221945 |
| 矿物油 | 330779 |
| 福美双 | 45689 |
| 视黄醇 | R7632 |
| 氯化钠 | S5886 |
| 硫酸镁 | M2643 |
| 黄嘌呤 | X4002 |
| 丁酸钠 | 303410 |
| 氯化钙 | C5670 |
| 油酸钠 | O7501 |
| 黄体酮 | V900699 |
| 琼脂糖 | V900510 |
| 甘氨酸 | V900144 |
| 氯化钾 | V900068 |
| 氯化钠 | V900058 |
| 尤达1 | SML1558 |
| 氯化钾 | P9541 |
| 黄体酮 | P0130 |
| 矿物油 | M5904 |
| 噻唑蓝 | M5655 |
| MES | M3671 |
| 氯化锂 | L9650 |
| 甘氨酸 | G8898 |
| 乙酸铵 | A1542 |
| 氯化钾 | 746436 |
| 氯化锂 | 449881 |
| 聚丙烯 | 427888 |
| 乙醇胺 | 411000 |
| 碳酸钾 | 367877 |
| 苯甲醇 | 305197 |
| 水杨酸 | 247588 |
| 氯化锂 | 203637 |
| 丙烯酸 | 147230 |
| 溴酚蓝 | 114391 |
| 月桂烯 | 64643 |
| 甜菜碱 | 61962 |
| 氯化钾 | 60128 |
| 芳樟醇 | 51782 |
| 草铵膦 | 45520 |
| 柠檬醛 | 43318 |
| 氧化铝 | 6300 |
| 乙酰胺 | 160 |
| 正己烷 | 34859 |
| 烟酰胺 | N0636 |
| 利福平 | R3501 |
| 黄芩素 | 465119 |
| 玉米油 | C8267 |
| 脂肪乳 | I141 |
| 槲皮素 | Q4951 |
| 生物素 | B4639 |
| 麦芽糖 | PHR1497 |
| 氯化锌 | 793523 |
| 甘氨酸 | 50046 |
| 硝酸银 | 204390 |
| 氯化锌 | 208086 |
| 碘化钠 | 383112 |
| 氯化钙 | 383147 |
| 苯甲醛 | 418099 |
| 苯甲醛 | B1334 |
| 胆固醇 | C8667 |
| 甘氨酸 | G8790 |
| 棕榈酸 | P0500 |
| PMA | P1585 |
| 视黄酸 | R2625 |
| 牛磺酸 | T8691 |
| 水杨酸 | S5922 |
| 乙酸钠 | S2889 |
| 生物素 | B4501 |
| 氯化钠 | S9625 |
| 氯化钠 | S7653 |
| 氯化钠 | S9888 |
| 氯化钠 | S3014 |
| 乙酸铵 | A7262 |
| 氧化铝 | 265497 |
| 碳酸钡 | 237108 |
| 碳酸钙 | 239216 |
| 麦草畏 | 45430 |
| 白消安 | B2635 |
| 碳酸铵 | 379999 |
| 正丁醇 | 281549 |
| 褪黑素 | M5250 |
| 柠檬醛 | C83007 |
| 偏磷酸 | 79615 |
| 苯乙烯 | S4972 |
| 三醋精 | 525073 |
| 叶黄素 | 7168 |
| 草甘膦 | 45521 |
| 氯化钾 | P3911 |
| 碳酸钾 | 209619 |
| 氧化铝 | 199443 |
| 乙酸铵 | 9689 |
| 氯化钾 | P9333 |
| 甲酚红 | 114472 |
| 氯化锌 | 429430 |
| 琼脂 | A1296 |
| 琼脂 | A7921 |
| 纯乙醇 | E7023 |
| 纤维素 | C6288 |
| 氯化钾 | P5405 |
| 氯化铵 | A9434 |
| 氯化钠 | S6191 |
| 异丙醇 | W292907 |
| 碘酸钠 | S4007 |
| 激动素 | K0753 |
| 甲酰胺 | F9037 |
| 硫酸铵 | A4418 |
| 二苯胺 | 242586 |
| 硫酸钠 | 238597 |
| 活性炭 | 161551 |
| 溶菌酶 | 62970 |
| 甲酰胺 | 47671 |
| 石蜡油 | 18512 |
| 磷酸 | 345245 |
| 尿素 | U0631 |
| 腺苷 | A4036 |
| 甲酸 | 33015 |
| 乙酸 | 338826 |
| 组胺 | H7125 |
| 酚红 | P3532 |
| 酚红 | 114529 |
| 油胺 | 909831 |
| 苯酚 | P1037 |
| 尿烷 | 94300 |
| 肌酐 | PHR1462 |
| 乙酸 | 45726-1L-F |
| 甘油 | G9012 |
| 皂素 | 47036 |
| 皂素 | 84510 |
| 皂素 | S4521 |
| 尿素 | U6504 |
| 尿素 | U5378 |
| 尿素 | U4884 |
| 尿素 | U1250 |
| 尿素 | U5128 |
| 丁酸 | B103500 |
| 乙酸 | A6283 |
| 乙酸 | 695092 |
| 顺铂 | 232120 |
| 乙酸 | 71251 |
| 甘油 | 49767 |
| 草酸 | 75688 |
| 片素 | L9283 |
| 片素 | 72511 |
| 油酸 | O1383 |
| 蔗糖 | V900116 |
| 甲酸 | W248703 |
| 甲酸 | 695076 |
| 甘油 | G5516 |
| 肌苷 | I4125 |
| 胸苷 | T1895 |
| 苯胺 | 242284 |
| 硼酸 | B0394 |
| 甲醇 | 34860 |
| 硅胶 | 717185 |
| 乙腈 | 34851 |
| 乙腈 | 360457 |
| 硅胶 | 214477 |
| 乙酸 | 27225 |
| 草酸 | 194131 |
| 甲酸 | F0507 |
| 咪唑 | I202 |
| 甘油 | G7757 |
| 硅胶 | 60741 |
| 碘 | 451045 |
| 碘 | 207772 |
| 䓛 | 35754 |
| 菲 | P11409 |
| 菲 | 695114 |
| 砂 | 274739 |
| 水 | W4502 |
| 水 | W1503 |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.
Berry & Associates的主要产品包括：
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
艾美捷科技代理Hybrid Plastics全系列倍半硅氧烷POSS化合物。
笼型倍半硅氧烷，具有无机立方核和外部有机基团的有机-无机杂化化合物。倍半硅氧烷是一种有机硅化合物，其化学式为[RSiO3/2]n（R=H，烷基，芳基或烷氧基）。倍半硅氧烷是无色固体，采用笼状或聚合结构，具有Si-O-Si键和四面体Si顶点。倍半硅氧烷是多八面体倍半硅氧烷（POSS）的一种，作为陶瓷材料和纳米复合材料的前驱体引起了人们的关注。不同的取代基（R）可以连接到Si中心。这些分子是不寻常的，因为它们具有无机硅酸盐核和有机表面。硅芯具有刚性和热稳定性。
Hybrid Plastics致力于提供全球最高质量的POSS®材料。具有ISO 9001:2008的质量管理体系，艾美捷科技有限公司与Hybrid Plastics Inc.长期合作，致力于为中国用户提供：Acrylates-POSS、Alcohols-POSS、Amines-POSS、Carboxylic Acids-POSS、Epoxides-POSS、Fluoroalkyls-POSS、Halides-POSS、Methacrylates-POSS、Molecular Silicas-POSS、Norbornenyls-POSS、Olefins-POSS、PEGs-POSS、Silanes-POSS、Silanols-POSS、Thiols-POSS等化合物。
MA0736 Acryloxypropyl POSS Cage mixture 现货销售 
MA0735 Methacryloxypropyl POSS 现货销售
AM0270 AminopropylIsooctyl POSS 现货销售 
产品主要包括：
http://www.amyjet.com/Index/lists/catid/27/kid/28.html
<| 货号品名 | 规格 |
| AL0125 – Trans-cyclohexandiol Isobutyl POSS | 1kg |
| AL0130 – 1,2-Propanediolisobutyl POSS | 1kg |
| AM0265 – AminopropylIsobutyl POSS | 100g,500g,1kg |
| AM0270 – AminopropylIsooctyl POSS | 100g,500g,1kg |
| AM0281 (Neat) – N-Phenylaminopropyl POSS | 25g,50g,100g,500g,1kg |
| AM0281.01.30 – N-Phenylaminopropyl POSS | 50g,1kg |
| EP0408.01.30 – Epoxycyclohexyl ethyl POSS cage mixture 30% PGMEA | 100g,1kg |
| EP0409 – Glycidyl POSS cage mixture | 100g,1kg |
| EP0409.07.30 – Glycidyl POSS Nanosilica Dispersion | 1kg |
| EP3530 – POSS Bond EP3530 | 1 Quart, 1 Gallon |
| HC0304.11 Cyclohexylepoxy Glycidyl POSS | |
| HC0310.31 – Cyclohexylethylepoxy isoOctyl POSS | |
| HC0313.31 – Cyclohexylethylepoxy PEG POSS | |
| HC0407.11 – Glycidyl Methacryl POSS | |
| HC0407.13 – Glycidyl Methacryl POSS | |
| HC0407.31 – Glycidyl Methacryl POSS | |
| HC040713.332 Glycidyl Methacryl PEG POSS | |
| HC0413.53 – Glycidyl PEG POSS | |
| HC0507.53 – Trifluoropropyl Methacrylpropyl POSS | |
| HC0613.53 – Acrylic PEG | |
| HC07051013.2211 Methacrylpropyl Trifluoropropyl iso-Octyl PEG POSS | |
| HC0709.13 Methacrylpropyl iso-butyl POSS | |
| HC0710.13 – Methacryloxypropyl isoOctyl POSS | |
| HC0713.31 – Methacryloxypropyl PEG POSS | |
| HC1110.71 Vinyl iso-Octyl POSS | |
| MA0701 – Acryloxypropyl isobutyl POSS | 1kg |
| MA0702 – Methacrylpropyloisobutyl POSS | 1kg |
| MA0719 – Methacryloxypropyl isooctyl POSS | 1kg |
| MA0735 – Methacryloxypropyl POSS | |
| MA0736 – Acryloxypropyl POSS Cage mixture | 100g,1kg |
| MA0735.08.30 – Methacrylic POSS Nanosilica Dispersion | |
| MA0736.08.30 – Acrylic POSS Nanosilica Dispersion | |
| MA0737 – Alpha Methacryl POSS | |
| MS0802 – DodecaPhenyl POSS | 1kg |
| MS0805 – OctaIsooctyl POSS | 1kg |
| MS0825 – OctaIsobutyl POSS | 1kg |
| MS0860 – OctaTMA POSS | 1kg |
| PG1190 – MethoxyPEG POSS cage mixture | 100g,500g,1kg |
| PG1193 HC1013.31 – MethoxyPEGisoOctyl POSS | |
| PM1270 – Phenyl Silanol Resin | 100g |
| SH1310 – Octasilane POSS | 50g |
| SO1450 – Trisilanol isobutyl POSS | 100g,1kg |
| SO1455 – TriSilanollsooctyl POSS | 100g,1kg |
| SO1458 – Trisilanol phenyl POSS | 100g,1kg |
| TH1555 – Mercaptopropyl isooctyl POSS | 50g,100g |
" data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Hybrid Plastics全系列倍半硅氧烷POSS化合物"> 艾美捷科技代理Hybrid Plastics全系列倍半硅氧烷POSS化合物
美国National Diagnostics（ND）向市场提供用于电泳的浓缩丙烯酰氨试剂的公司（推介于FASEB 1986）；第一个研发出可生物降解的闪烁计数混合液；也第一个推出了可生物降解的橙子油来作为代替二甲苯的组织透明剂。
National Diagnostics is a principle world source for the development and manufacture of chemicals and related products for scientific research. We are particularly proud of the innovations we have made to improve laboratory safety and reduce the environmental impact of research. The National Diagnostics label on any product is an assurance of the highest level of quality and that all raw materials and finished products adhere to the most stringently controlled specifications.
National Diagnostics的主要产品包括：
Electrophoresis
Histology
Oxygen Assay
Liquid Scintillation
Electro-Optical
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
Empire Genomics创立于2006，研究始于纽约布法罗著名的罗斯威尔公园癌症研究所。该实验室在开发高通量技术方面有很强的优势，能够进行全基因组分析，以确定疾病的潜在机制。Empire Genomics在人类基因组计划中发挥了重要作用，创造了作为基因组测序基础的细菌人工染色体，在基因组研究中发挥了重要的专门知识。正是基于这种强大的经验基础，我们才有能力、工具和技术支持研究、临床和药物发现。
Empire Genomics is a clinical molecular diagnostics company. We offer a comprehensive menu of products and services that are used in guiding precise treatments for patients. We work with our clinical, research and biopharmaceutical clients to create innovative and custom solutions to make personalized medicine a reality.
Empire Genomics公司的主要产品包括：
ID Labs Products
FISH Probes
BAC Clones
Genotyping
Circulating Tumor Cells
Gene Expression Services
Custom Services
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://icl.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Empire Genomics"> Empire Genomics地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：13212737804
传真：15172431432
邮箱：sales@amyjet.com
0.5629
